Friday, 22 September 2017

Roche receives EU approval for Gazyvaro, European approval for Actemra

ZURICH (Reuters) - Roche said it has received European approval for its Actemra medication in giant cell arteritis (GCA), the Swiss drugmaker said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)